Covered recipient · General Payments record

AMANDA LEE RUXTON

Allopathic & Osteopathic Physicians Family Medicine

NPI: 1457511321
CMS profile: 689846
Location: EMPORIA, KS

General Payments · PY2018–2024

$4,528.55

Reported across 303 records
CMS publication 2026-01-23

Latest program year · PY2024

$952.60

55 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of payment	Amount	Records
Food and Beverage	$952.60	55

By paying entity

PY2024 · sorted by reported total

Paying entity	Amount	Records
ABBVIE INC.	$158.92	16
Acerta Pharma LLC	$139.29	2
Phathom Pharmaceuticals, Inc.	$120.58	6
Novo Nordisk AS	$97.27	5
Lilly USA, LLC	$65.46	4
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$58.04	4
Bayer HealthCare Pharmaceuticals Inc.	$52.22	3
Amgen Inc.	$41.48	2
Mylan Specialty L.P.	$34.06	2
PFIZER INC.	$27.76	2
ITI, Inc.	$21.74	1
Vanda Pharmaceuticals Inc.	$20.90	1
Axsome Therapeutics, Inc.	$19.96	1
E.R. Squibb & Sons, L.L.C.	$18.56	1
Otsuka America Pharmaceutical, Inc.	$17.89	1
GlaxoSmithKline, LLC.	$15.68	1
Teva Pharmaceuticals USA, Inc.	$14.43	1
Abbott Laboratories	$14.19	1
Takeda Pharmaceuticals U.S.A., Inc.	$14.17	1

By program year

All program years on this page · sorted by year

Program year	Amount	Records
PY2018	$104.78	7
PY2019	$73.47	5
PY2020	$685.53	50
PY2021	$1,071.63	81
PY2022	$750.65	48
PY2023	$889.89	57
PY2024	$952.60	55

Payment records · PY2024 (55)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018 2019 2020 2021 2022 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.

Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Record ID	Source
Abbott Laboratories	$14.19	09/16/2024	Food and Beverage	Undisputed	01/23/2026	1125075154	CMS
ABBVIE INC.	$5.41	01/10/2024	Food and Beverage	Undisputed	01/23/2026	1105991890	CMS
ABBVIE INC.	$4.36	01/31/2024	Food and Beverage	Undisputed	01/23/2026	1105991892	CMS
ABBVIE INC.	$19.55	02/01/2024	Food and Beverage	Undisputed	01/23/2026	1105991894	CMS
ABBVIE INC.	$3.82	02/28/2024	Food and Beverage	Undisputed	01/23/2026	1105991896	CMS
ABBVIE INC.	$5.30	04/10/2024	Food and Beverage	Undisputed	01/23/2026	1105991898	CMS
ABBVIE INC.	$14.10	05/01/2024	Food and Beverage	Undisputed	01/23/2026	1105991900	CMS
ABBVIE INC.	$6.06	05/08/2024	Food and Beverage	Undisputed	01/23/2026	1105991902	CMS
ABBVIE INC.	$26.19	06/05/2024	Food and Beverage	Undisputed	01/23/2026	1105991904	CMS
ABBVIE INC.	$6.39	06/14/2024	Food and Beverage	Undisputed	01/23/2026	1105991906	CMS
ABBVIE INC.	$16.35	07/03/2024	Food and Beverage	Undisputed	01/23/2026	1105991908	CMS
ABBVIE INC.	$10.31	07/29/2024	Food and Beverage	Undisputed	01/23/2026	1105991910	CMS
ABBVIE INC.	$5.15	09/11/2024	Food and Beverage	Undisputed	01/23/2026	1105991912	CMS
ABBVIE INC.	$1.58	10/09/2024	Food and Beverage	Undisputed	01/23/2026	1105991914	CMS
ABBVIE INC.	$17.19	10/21/2024	Food and Beverage	Undisputed	01/23/2026	1105991916	CMS
ABBVIE INC.	$9.35	11/22/2024	Food and Beverage	Undisputed	01/23/2026	1105991918	CMS
ABBVIE INC.	$7.81	12/03/2024	Food and Beverage	Undisputed	01/23/2026	1105991920	CMS
Amgen Inc.	$15.87	05/13/2024	Food and Beverage	Undisputed	01/23/2026	1117371487	CMS
Amgen Inc.	$25.61	10/16/2024	Food and Beverage	Undisputed	01/23/2026	1117371489	CMS
AstraZeneca Pharmaceuticals LP	$122.28	01/22/2024	Food and Beverage	Undisputed	01/23/2026	1105362271	CMS
AstraZeneca Pharmaceuticals LP	$17.01	02/15/2024	Food and Beverage	Undisputed	01/23/2026	1104517192	CMS
Axsome Therapeutics, Inc.	$19.96	05/22/2024	Food and Beverage	Undisputed	01/23/2026	1148263167	CMS
Bayer Healthcare Pharmaceuticals Inc.	$16.28	02/21/2024	Food and Beverage	Undisputed	01/23/2026	1086173912	CMS
Bayer Healthcare Pharmaceuticals Inc.	$19.38	04/17/2024	Food and Beverage	Undisputed	01/23/2026	1086132050	CMS
Bayer Healthcare Pharmaceuticals Inc.	$16.56	12/04/2024	Food and Beverage	Undisputed	01/23/2026	1086236794	CMS
E.R. Squibb & Sons, L.L.C.	$18.56	12/02/2024	Food and Beverage	Undisputed	01/23/2026	1101341919	CMS
GlaxoSmithKline, LLC.	$15.68	08/12/2024	Food and Beverage	Undisputed	01/23/2026	1116650501	CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$21.74	04/05/2024	Food and Beverage	Undisputed	01/23/2026	1143311381	CMS
Lilly USA, LLC	$14.39	02/28/2024	Food and Beverage	Undisputed	01/23/2026	1136028987	CMS
Lilly USA, LLC	$16.54	03/20/2024	Food and Beverage	Undisputed	01/23/2026	1136026820	CMS
Lilly USA, LLC	$18.74	05/08/2024	Food and Beverage	Undisputed	01/23/2026	1136021852	CMS
Lilly USA, LLC	$15.79	06/27/2024	Food and Beverage	Undisputed	01/23/2026	1136027886	CMS
Mylan Specialty L.P.	$18.70	02/19/2024	Food and Beverage	Undisputed	01/23/2026	1147325180	CMS
Mylan Specialty L.P.	$15.36	04/03/2024	Food and Beverage	Undisputed	01/23/2026	1147340245	CMS
Novo Nordisk Inc	$16.22	02/12/2024	Food and Beverage	Undisputed	01/23/2026	1096740263	CMS
Novo Nordisk Inc	$18.12	04/11/2024	Food and Beverage	Undisputed	01/23/2026	1097369844	CMS
Novo Nordisk Inc	$19.87	10/02/2024	Food and Beverage	Undisputed	01/23/2026	1097187420	CMS
Novo Nordisk Inc	$16.98	10/30/2024	Food and Beverage	Undisputed	01/23/2026	1096582623	CMS
Novo Nordisk Inc	$26.08	11/07/2024	Food and Beverage	Undisputed	01/23/2026	1097566636	CMS
Otsuka America Pharmaceutical, Inc.	$17.89	11/25/2024	Food and Beverage	Undisputed	01/23/2026	1118973746	CMS
PFIZER INC.	$13.26	06/10/2024	Food and Beverage	Undisputed	01/23/2026	1131636927	CMS
PFIZER INC.	$14.50	08/28/2024	Food and Beverage	Undisputed	01/23/2026	1131979408	CMS
Phathom Pharmaceuticals, Inc.	$19.19	03/06/2024	Food and Beverage	Undisputed	01/23/2026	1151118764	CMS
Phathom Pharmaceuticals, Inc.	$20.82	04/09/2024	Food and Beverage	Undisputed	01/23/2026	1151118766	CMS
Phathom Pharmaceuticals, Inc.	$16.15	07/02/2024	Food and Beverage	Undisputed	01/23/2026	1151118768	CMS
Phathom Pharmaceuticals, Inc.	$24.66	10/28/2024	Food and Beverage	Undisputed	01/23/2026	1151118770	CMS
Phathom Pharmaceuticals, Inc.	$19.96	11/13/2024	Food and Beverage	Undisputed	01/23/2026	1151118772	CMS
Phathom Pharmaceuticals, Inc.	$19.80	12/18/2024	Food and Beverage	Undisputed	01/23/2026	1151118774	CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$13.93	04/25/2024	Food and Beverage	Undisputed	01/23/2026	1153462254	CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$16.82	06/06/2024	Food and Beverage	Undisputed	01/23/2026	1153514196	CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$14.01	10/09/2024	Food and Beverage	Undisputed	01/23/2026	1153511515	CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$13.28	10/09/2024	Food and Beverage	Undisputed	01/23/2026	1153649846	CMS
Takeda Pharmaceuticals U.S.A., Inc.	$14.17	03/25/2024	Food and Beverage	Undisputed	01/23/2026	1137665986	CMS
Teva Pharmaceuticals USA, Inc.	$14.43	07/31/2024	Food and Beverage	Undisputed	01/23/2026	1151656403	CMS
Vanda Pharmaceuticals Inc.	$20.90	09/30/2024	Food and Beverage	Undisputed	01/23/2026	1133918755	CMS

Source & provenance

Dataset: CMS Open Payments — General Payments
Publisher of source data: Centers for Medicare & Medicaid Services
CMS publication date: 2026-01-23
Program years on this page: 2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files: Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.